Arterial Blood Gases (ABG) and Respiratory Therapy Study Guide

Arterial Blood Gas (ABG) Interpretation

  • Respiratory Component: This component controls the partial pressure of carbon dioxide (PaCO2PaCO_2).     * The carbon dioxide (CO2CO_2) is considered an acid, which is primarily controlled by the lungs.     * A high level of PaCO2PaCO_2 indicates a state of Acidosis.     * A low level of PaCO2PaCO_2 indicates a state of Alkalosis.

  • Metabolic Component: This component controls the bicarbonate level (HCO3HCO_3^-).     * Bicarbonate is considered a base, which is primarily controlled by the kidneys.     * As per the provided guide: A high level of bicarbonate (HCO3HCO_3^-) indicates Acidosis.     * As per the provided guide: A low level of bicarbonate (HCO3HCO_3^-) indicates Alkalosis.

Levels of Compensation in Acid-Base Status

  • Uncompensated: A state where one value (either PaCO2PaCO_2 or HCO3HCO_3^-) is abnormal while the other remains within range, resulting in an abnormal pHpH.

  • Partial Compensation: A state where both the CO2CO_2 and the HCO3HCO_3^- are abnormal, and the pHpH remains abnormal. In this scenario, if one value represents the primary acid-base problem, the other value is actively shifting in an attempt to compensate for that imbalance.

  • Full Compensation: A state characterized by a normal pHpH, while both the CO2CO_2 and HCO3HCO_3^- values remain abnormal.

  • Respiratory Problems: In these cases, the kidneys attempt to compensate. For example, in Respiratory Acidosis, the kidneys respond by increasing the level of HCO3HCO_3^- (bicarbonate).

  • Metabolic Problems: In these cases, the lungs attempt to compensate. For example, in Metabolic Acidosis, the lungs respond by decreasing the level of PaCO2PaCO_2 (carbon dioxide) through increased ventilation.

Evaluation of Oxygenation Status

  • Normal Oxygenation: Defined as a PaO2PaO_2 between 8010080-100.

  • Mild Hypoxemia: Defined as a PaO2PaO_2 between 607960-79.

  • Moderate Hypoxemia: Defined as a PaO2PaO_2 between 405940-59.

  • Severe Hypoxemia: Defined as a PaO2PaO_2 less than 4040 (< 40).

Clinical ABG Interpretation Scenario

  • Patient Profile: A 6868-year-old patient with Chronic Obstructive Pulmonary Disease (COPD) presents in the Emergency Room (ER).

  • Clinical Presentation: Shortness of breath, drowsiness, and shallow breathing.

  • ABG Results:     * pH 7.29pH \text{ } 7.29     * PaCO2 58mmHgPaCO_2 \text{ } 58\,mmHg     * HCO3 30mEq/LHCO_3^- \text{ } 30\,mEq/L     * PaO2 60mmHgPaO_2 \text{ } 60\,mmHg

  • Scenario Evaluation:     * Acid-Base Status: Respiratory Acidosis (due to low pHpH and high PaCO2PaCO_2).     * Compensation Status: Partially compensated (both PaCO2PaCO_2 and HCO3HCO_3^- are elevated, but pHpH has not returned to normal range).     * Oxygenation Status: Hypoxemia (specifically mild hypoxemia based on the value of 60mmHg60\,mmHg).     * Primary Clinical Concern: Ventilation failure.

Ventilation Concepts: Hypoventilation vs. Hyperventilation

  • Hypoventilation:     * Definition: Breathing that is too slow or too shallow.     * Physiological Effect: The body holds on to carbon dioxide (CO2CO_2).     * Blood Chemistry: Results in an increase in CO2CO_2, making the blood more acidic.     * Primary Association: Associated with respiratory acidosis.

  • Hyperventilation:     * Definition: Breathing that is too fast or too deep.     * Physiological Effect: The body is "blowing off" too much carbon dioxide (CO2CO_2).     * Blood Chemistry: Results in a decrease in CO2CO_2, making the blood more basic.     * Primary Association: Associated with respiratory alkalosis.

  • Summary of Effects on PaCO2PaCO_2 and pHpH:     * Hyperventilation effects: pHpH increases, PaCO2PaCO_2 decreases, and HCO3HCO_3^- remains normal.     * Hypoventilation effects: pHpH decreases, PaCO2PaCO_2 increases, and HCO3HCO_3^- may increase if compensation is occurring.

Pulmonary Function and Ventilation Definitions

  • Minute Ventilation (VEV_E):     * Definition: The total volume of air exhaled per minute.     * Measurement Device: Measured using a Wright's spirometer.     * Calculation: VE=VT×fV_E = V_T \times f     * Normal Value: 57L/min5-7\,L/min     * Acceptable Value: < 10\,L/min

  • Tidal Volume (VTV_T):     * Definition: The volume of air inhaled and exhaled with each individual breath.     * Normal Range: 57ml/kg5-7\,ml/kg of Ideal Body Weight (IBW).     * Note: The full range is found by multiplying the IBW by the low and high ends of the normal range.

  • Frequency (ff): Refers to the Respiratory Rate (RR).

  • Vital Capacity (VCVC):     * Definition: The maximum amount of air a person can exhale after a maximum inspiration.     * Normal Value: 6575ml/kg65-75\,ml/kg of IBW.     * Note: To find the range, multiply the IBW by the normal specific volume values.

  • Alveolar Ventilation (VAV_A):     * Definition: The volume of air per minute that actually participates in gas exchange.     * Calculation: (VTVD)×f(V_T - V_D) \times f     * Normal Value: Greater than 60%60\% of the total Minute Ventilation (VEV_E).

  • Dead Space (VDV_D):     * Definition: The amount of volume per breath that does NOT participate in gas exchange (e.g., air in the conducting airways).     * Calculation (ml): 1mL1\,mL per pound (lblb) of IBW.     * Calculation in Liters Per Minute (LPM): VD(in ml)×FrequencyV_D(\text{in ml}) \times \text{Frequency}.

Weaning Parameters and Forced Expiration

  • Negative Inspiratory Force (NIF):     * Measurement Device: Pressure manometer.     * Definition: The amount of negative pressure generated by the patient when attempting to inhale.     * Clinical Utility: Measures the negative inspiratory force.     * Normal Value: Greater than 60cmH2O-60\,cmH_2O.     * Acceptable Value: Greater than 20cmH2O-20\,cmH_2O.

  • Rapid Shallow Breathing Index (RSBI):     * Measurement Device: Wright's spirometer.     * Calculation: RSBI=f/VT (in liters)RSBI = f / V_T \text{ (in liters)}     * Normal: < 50\text{ cycles/L}     * Acceptable: < 100\text{ cycles/L}     * Weaning Candidate Threshold: Individuals with an RSBI < 105 are considered candidates for weaning from mechanical ventilation.

  • Peak Flow Meter:     * Definition of Peak Expiratory Flow Rate (PEFR): The maximum flow rate achieved during a forced exhalation starting from a point of maximum inspiration.     * Determinants of Normal Values: Calculated based on the patient's age, gender, size (height), and any chronic disease processes.

Oxygen Therapy and Delivery Devices

  • Low Flow Oxygen Systems:     * Characteristics: Provides a variable FiO2FiO_2 depending on the patient's inspiratory demand.     * Example Devices: Nasal Cannula, Simple Mask.

  • High Flow Oxygen Systems:     * Characteristics: Provides a fixed, precise FiO2FiO_2.     * Example Devices: Venturi mask, Air entrainment systems.

  • Indications for Device Selection: When choosing an oxygen device, consider the required FiO2FiO_2, the duration of therapy, the specific oxygen system available, and the route of administration.

  • Troubleshooting Equipment Issues:     * Check for kinks in the tubing.     * Inspect all connections for leaks.

  • Oxygen Considerations for COPD Patients:     * Care must be taken with flow rates; excessive oxygen administration can potentially suppress the patient's hypoxic drive to breathe.     * Devices such as the Opti-flow are used for these patients.     * Target oxygen saturation levels for COPD patients are generally between 8892%88-92\%.

Airway Management

  • Oropharyngeal Airway (OPA): Indicated for unconscious patients who lack a gag reflex.

  • Nasopharyngeal Airway (NPA): Indicated for semi-conscious patients who are breathing spontaneously.

  • Airway Emergencies and Complications:     * Recognize signs such as increased Work of Breathing (WOB), apnea, or a decreased Level of Consciousness (LOC).     * Monitor for the Vagal response, which results in a decreased Heart Rate (HR).     * Be aware that high cuff pressure on an endotracheal tube can cause tracheal damage.

Intermittent Positive Pressure Breathing (IPPB)

  • Device: Bird Mark 7.

  • Triggering (TLC): The breath can be initiated by the patient, manually, or by an apnea timer (though apnea settings are no longer commonly used).

  • Sensitivity:     * Definition: Determines how much effort is required from the patient to start a breath.     * More Sensitive: Easier for the patient to trigger; requires less effort.     * Less Sensitive: Harder for the patient to trigger; requires more effort.

  • Flow: This is limited and constant. It only changes if the Respiratory Therapist (RT) manually adjusts it.

  • Pressure and Cycles:     * Low Compliance: Airway pressure is reached faster because it takes less time to fill the lung, resulting in a shorter inspiratory time (ITIMEI-TIME). Typical in "stiff" lungs, such as those with ARDS or pulmonary edema.     * High Compliance: It takes longer for the patient to reach the set pressure before the device cycles the breath. Typical in "stretchy" or "floppy" lungs, such as those with COPD.

  • Function: Used to treat and prevent atelectasis.

  • Troubleshooting IPPB:     * If the patient cannot trigger the breath, adjust the sensitivity.     * Reposition the patient.     * Coach the patient on their breathing technique and improve the mask seal.     * Check for kinks in the tubing.

Humidity and Aerosol Therapy

  • Purpose of Humidity: To add moisture to inspired gas to prevent the drying and irritation of the airway mucosa and to prevent bronchospasms.

  • Humidity Devices:     * Bubble Humidifier: Oxygen is bubbled through water.     * Passover Humidifier: Gas passes over the surface of heated water.     * Heated Humidifier: Both warms and humidifies the gas.

  • Aerosol Devices:     * Jet Nebulizer: Compressed gas turns liquid medication into a mist.     * Ultrasonic Nebulizer: Uses high-frequency sound waves to create aerosol particles.     * Mesh Nebulizer: Uses a vibrating mesh plate to create aerosols.     * Metered Dose Inhaler (MDI): A handheld spray medication, often used with a spacer for better delivery.

  • Principles of Therapy:     * Aerosol factors: Includes particle size, deposition location, airway condition, particle behavior, and the efficiency of the device.     * Humidity benefits: Protects the mucosa, prevents bronchospasm, and keeps secretions thin and mobile.

  • Infection Control Practices:     * Utilize sterile technique and sterile water.     * Replace equipment when needed.     * Dedicate devices to a single patient.     * Clean and disinfect thoroughly to avoid the contamination of reservoirs.

Secretion Management and Breathing Patterns

  • Airway Clearance Techniques:     * Chest Physiotherapy (CPT): Moves mucus to central airways where it can be cleared.     * Postural Drainage: Uses gravity and positioning to break up and move mucus.     * Incentive Spirometer (IS): Used for lung expansion therapy.     * Positive Expiratory Pressure (PEP): Assists in clearing secretions.

  • Sputum Assessment (Infection Signs):     * Color Change: Yellow, green, or brown (indicative of old blood or pneumonia).     * Thickness: Thick or sticky consistency.     * Amount: An increase in regular sputum production.     * Odor: Foul-smelling or purulent odors indicate bacterial infection.     * Clinical Signs: Changes in oxygen levels or breath sounds.

  • Abnormal Breathing Patterns:     * Kussmaul: Breathing that is deep and fast; used by the body to blow off excess CO2CO_2.     * Cheyne-Stokes: A repetitive cycle of deep breathing followed by shallow breathing and then a period of apnea.     * Biot’s: Irregular breathing interspersed with random periods of apnea; described as "chaotic."     * Apnea: No breathing; requires immediate intubation.     * Paradoxical Breathing: The chest wall moves in the opposite direction of the abdomen during respiration.

  • Physical Findings in Distress:     * Cyanosis (blue tint to skin).     * Anxiety.     * Use of accessory muscles to breathe.     * Tripoding position.

Emergency, Critical Care, and Pharmacology

  • Assessment Steps: Palpate, percuss, listen to breath sounds, and evaluate the Level of Consciousness (LOC) to see if the patient can follow directions.

  • Emergency Lab Values:     * S (transcript placeholder).

  • Overdose and Trauma:     * S (transcript placeholder).

  • Equipment Failure and Maintenance:     * Respond to equipment failure: A (transcript placeholder).     * Common malfunctions: Deflated cuff on an airway, kinks in tubing, bulb not tightened on a laryngoscope blade, or cross-threaded connections.

  • Oxygen Cylinder Duration Formulas:     * E Cylinder: Pressure×0.28=Time in mins\text{Pressure} \times 0.28 = \text{Time in mins}     * H Cylinder: Pressure×3.14=Time in mins\text{Pressure} \times 3.14 = \text{Time in mins}

  • Pharmacology Basics:     * Bronchodilators: Used to open airways (Beta 2 agonists). Examples: Albuterol, Levalbuterol (typically ending in "-rol").     * Mucolytics: Used to thin and loosen mucus. Example: Acetylcysteine (Mucomyst).     * Diuretics: Used to remove excess fluid from the body. Example: Furosemide (Lasix).     * Corticosteroids: Used to reduce airway inflammation and swelling. Examples: Pulmicort, Inhaled Fluticasone, and Prednisone.

  • Clinical Judgment and Prioritization:     * The highest priority is always to protect the airway.     * Recognize urgency: Determine if a patient requires immediate attention or can safely wait in a waiting room.     * Bedside thinking: Apply practical knowledge gained from simulation lab days.